| Recruiting | N/A | 300 | Europe, US | LYNX EYE (Lynch syndrome X-Talk of Enteral mucosa with Immune System) | San Raffaele University | Lynch Syndrome, Lynch Syndrome I, Lynch Syndrome II, Lynch Syndrome I (Site-specific Colonic Cancer), HNPCC, HNPCC Gene Mutation, Hereditary Cancer Syndrome, Hereditary Cancer, MLH1 Gene Mutation, MLH1 Gene Deletion+Duplication, MLH1 Loss of Expression, MLH1 Gene Inactivation, MSH2 Gene Mutation, MSH2 Gene Deletion+Duplication, MSH2 Loss of Expression, MSH2 Gene Inactivation, MSH6 Gene Mutation, MSH6 Loss of Expression, MSH6 Gene Inactivation, PMS2 Gene Mutation, PMS2 Gene Inactivation, PMS2 Loss of Expression | 06/33 | 06/34 | | |
| Recruiting | N/A | 2750 | Europe | No intervention | Lallemand Pharma AG, Istituto di Farmacologia Traslazionale - National Research Council (IFT-CNR) | Healthy Adults, Not Healthy Adults | 05/25 | 05/25 | | |